King's College Hospital is a major trauma centre in Denmark Hill, Camberwell in the London Borough of Lambeth, referred to locally and by staff simply as "King's" or abbreviated internally to "KCH". It is managed by King's College Hospital NHS Foundation Trust.

There are 950 beds in King's College Hospital.

During the past decade, King's College Hospital conducted 469 clinical trials. In the 10-year time frame, 469 clinical trials started and 158 clinical trials were completed, i.e. on average, 33.7% percent of trials that started reached the finish line to date. In the past 5 years, 194 clinical trials started and 84 clinical trials were completed. i.e. 43.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King's College Hospital" #1 sponsor was "King's College Hospital NHS Trust" with 83 trials, followed by "Gilead Sciences" with 40 trials sponsored, "King's College London" with 34 trials sponsored, "Hoffmann-La Roche" with 23 trials sponsored and "Janssen Research & Development, LLC" with 23 trials sponsored. Other sponsors include 520 different institutions and companies that sponsored additional 271 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King's College Hospital" #1 collaborator was "King's College Hospital NHS Trust" with 40 trials as a collaborator, "King's College London" with 39 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 15 trials as a collaborator, "Guy's and St Thomas' NHS Foundation Trust" with 13 trials as a collaborator and "Barts & The London NHS Trust" with 8 trials as a collaborator. Other collaborators include 656 different institutions and companies that were collaborators in the rest 451 trials.

According to Clinical.Site data, the most researched conditions in "King's College Hospital" are "Coronary Artery Disease" (17 trials), "Multiple Myeloma" (16 trials), "Myelodysplastic Syndromes" (14 trials), "Heart Failure" (11 trials) and "Hepatitis B, Chronic" (11 trials). Many other conditions were trialed in "King's College Hospital" in a lesser frequency.

Most popular intervention types in "King's College Hospital" are "Drug" (411 trials), "Other" (116 trials), "Device" (115 trials), "Procedure" (51 trials) and "Biological" (45 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (115 trials), "Dexamethasone" (10 trials), "Rituximab" (10 trials), "Azacitidine" (9 trials) and "Bortezomib" (8 trials). Other intervention names were less common.

The vast majority of trials in "King's College Hospital" are 691 trials for "All" genders, 21 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are 244 active trials in "King's College Hospital". 7 are not yet recruiting, 151 are recruiting, 83 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 349 completed trials in King's College Hospital, 2 suspended trials, and 62 terminated clinical trials to date.

Out of the total trials that were conducted in King's College Hospital, 55 "Phase 1" clinical trials were conducted, 188 "Phase 2" clinical trials and 235 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 35 trials, and there were also 131 trials that are defined as “Not Applicable".

King's College Hospital has several departments that took part in Clinical trials: "Institute of Liver Studies, King's College Hospital" - 7 trials, "King'S College Hospital; Haematology" - 4 trials